Scientists and business leaders dedicate their unparalleled expertise to developing pharmaceutical products based on new chemical and biological entities and on sophysticated drug delivery technologies with the main goal to enhance therapeutic outcomes in major diseases.
Paolo Alberto Veronesi
Chief Executive Officer and R&D Director
Paolo Alberto Veronesi serves as Chief Executive Officer and R&D Director for Therapicon. As a major company founder, he is overseeing all aspects of product research and development, regulatory, quality and manufacturing (as Qualified Person), business development, collaborative agreements, and products commercialization. Prior to joining Therapicon, as from 1969 Paolo held various positions in different leading pharmaceutical companies (Farmitalia SpA, Recordati SpA and Poli SpA), where he worked throughout worldwide operations, including production, marketing, sales, business development and regulatory affairs in both the pharmaceutical and API's divisions. He is a Ph.D. (Modena University).
Emanuela Peschechera leads the Regulatory and Quality departments (as Qualified Person), including Quality Assurance, Validation, Quality Control, Microbiology and Compliance. She received her CTF (Pharmaceutical Technolgy) degree from Milan University.
Logistic and Operations
Paola Mauri leads the Logistic and Operations, including wordwide supply chain, including manufaturing planning and sales-export operations.
Therapicon® is a registered trade-mark in Italy and at OMPI (WIPO)-Geneva